These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11439970)

  • 1. Effects of topiramate on cognition.
    Meador KJ
    J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):134-5. PubMed ID: 11439970
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of topiramate on cognitive function.
    Thompson PJ; Baxendale SA; Duncan JS; Sander JW
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):636-41. PubMed ID: 11032616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy.
    Jansen JF; Aldenkamp AP; Marian Majoie HJ; Reijs RP; de Krom MC; Hofman PA; Eline Kooi M; Nicolay K; Backes WH
    Epilepsy Behav; 2006 Aug; 9(1):181-5. PubMed ID: 16793345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of adjunctive topiramate on cognitive function in patients with epilepsy.
    Lee S; Sziklas V; Andermann F; Farnham S; Risse G; Gustafson M; Gates J; Penovich P; Al-Asmi A; Dubeau F; Jones-Gotman M
    Epilepsia; 2003 Mar; 44(3):339-47. PubMed ID: 12614389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate: potential trade-offs between efficacy and tolerability in the treatment of epilepsy.
    Harvey AS
    J Paediatr Child Health; 2003 Aug; 39(6):414-5. PubMed ID: 12919492
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up.
    Lee HW; Jung DK; Suh CK; Kwon SH; Park SP
    Epilepsy Behav; 2006 Jun; 8(4):736-41. PubMed ID: 16647301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective preference for lamotrigine or topiramate in healthy volunteers: relationship to cognitive and behavioral functioning.
    Werz MA; Schoenberg MR; Meador KJ; Loring DW; Ray PG; Kaul-Gupta R; Ogrocki P
    Epilepsy Behav; 2006 Feb; 8(1):181-91. PubMed ID: 16377253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.
    Kockelmann E; Elger CE; Helmstaedter C
    Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erectile dysfunction with topiramate.
    Holtkamp M; Weissinger F; Meierkord H
    Epilepsia; 2005 Jan; 46(1):166-7. PubMed ID: 15660786
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term treatment retention with topiramate.
    Deckers CL; Renier WO
    Epilepsia; 2001 Feb; 42(2):290-1. PubMed ID: 11240609
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of topiramate on attention.
    Burton LA; Harden C
    Epilepsy Res; 1997 Apr; 27(1):29-32. PubMed ID: 9169288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible facial myoclonus with topiramate therapy for epilepsy.
    Kutluay E; Pakoz B; Beydoun A
    Epilepsia; 2007 Oct; 48(10):2001-2. PubMed ID: 17922777
    [No Abstract]   [Full Text] [Related]  

  • 14. [Compared clinical study on treatment of childhood epilepsy with different escalating dosage protocol of topiramate].
    Huang SP; He GZ; Chen ZQ; He J
    Zhonghua Er Ke Za Zhi; 2003 Mar; 41(3):230-2. PubMed ID: 14756968
    [No Abstract]   [Full Text] [Related]  

  • 15. [Weight loss associated with topiramate treatment].
    Maciá- Bobes C; Cortejoso-García R; Carrio-Montes I; Arias Rodríguez M
    Rev Neurol; 2002 Feb 16-28; 34(4):397. PubMed ID: 12022061
    [No Abstract]   [Full Text] [Related]  

  • 16. Topiramate extended-release (Trokendi XR) for epilepsy.
    Med Lett Drugs Ther; 2013 Oct; 55(1428):87-8. PubMed ID: 24165709
    [No Abstract]   [Full Text] [Related]  

  • 17. Topiramate for epilepsy.
    Med Lett Drugs Ther; 1997 May; 39(1001):51-2. PubMed ID: 9164447
    [No Abstract]   [Full Text] [Related]  

  • 18. Topiramate and metabolic acidosis.
    Wilner A; Raymond K; Pollard R
    Epilepsia; 1999 Jun; 40(6):792-5. PubMed ID: 10368081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life.
    Kerr MP; Baker GA; Brodie MJ
    Epilepsy Behav; 2005 Nov; 7(3):472-80. PubMed ID: 16140593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of being seizure free: topiramate and psychopathology in epilepsy.
    Mula M; Trimble MR
    Epilepsy Behav; 2003 Aug; 4(4):430-4. PubMed ID: 12899865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.